Answer:
option (b) 12.77 percent
Explanation:
Data provided in the question:
Expected return = 15.72% = 0.1572
Beta = 1.33
Risk free rate = 3.82% = 0.0382
Inflation rate = 2.95% = 0.0295
Now,
Expected return = Risk free rate + Beta × (Expected market return - Risk free rate)
or
0.1572 = 0.0382 + 1.33 × ( Expected market return - 0.0382 )
or
0.119 = 1.33 × ( Expected market return - 0.0382 )
or
Expected market return - 0.0382 = 0.08947
or
Expected market return = 0.12767
or
Expected market return = 0.12767 × 100% = 12.767% ≈ 12.77%
option (b) 12.77 percent
Answer:
b.0.22
Explanation:
Return on investment (ROI) = Operating income/ Beginning Operating Asset = $ 92,000/ $440,000 = 0.22
Given a 7 percent interest rate, compute the present value of payments made in years 1, 2, 3, and 4 of $1,350, $1,550, $1,550, a
igor_vitrenko [27]
Answer:
The present value of cash flows is $ 5,292.13
Explanation:
The present value is today's equivalence of the company's future cash flow discounted using the 7% interest rate as a discount rate.
Formula for pv of a cash flow=cash flow/(1+r)^n
r is the 7% interest rate
n is the relevant year each cash flow relates to
PV=$1,350/(1+7%)^1+$1550/(1+7%)^2+$1550/(1+7%)^3+$1850/(1+7%)^4=
$ 5,292.13
<span>Both the medical model and the public health model have in common a desire to educate people about their health, healthy options, and consequences of not paying attention to health issues. The medical model may, at times, include too much information for some to understand the bottom-line, while the public health model may be watered down in an attempt to reach the masses.</span>
The answer is "open innovation".
It is because that organizations have found that with a specific end goal to create enough helpful new item thoughts, they have to make utilization of open advancements by which an association creates key connections to outside individual or association keeping in mind the end goal to make new item thoughts. Open innovation is a term used to advance a data age outlook toward advancement that runs counter to the mystery and storehouse mindset of conventional corporate research labs.
